Brief: Bard1 Life Sciences Says FY Loss Before Tax A$14 Mln
31/08/2021 09:57
Aug 31 (Reuters) - BARD1 Life Sciences Ltd BD1.AX :
* FY LOSS BEFORE TAX A$14MLN VERSUS A$3.3 MILLION
Source text for Eikon: ID:nASXf7Nhj
Further company coverage: BD1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inoviq
See all newsBrief: Inoviq Posts FY26 Net Loss After Tax A$7.5 Million
Brief: INOVIQ Requests Trading Halt
Brief: INOVIQ Says Peter Gunzburg Elected To Role Of Chairman
Brief: Inoviq Says Chairman David Williams To Step Down At Year-End
Australia's INOVIQ slips to 2-1/2-month low on $6.2 million discounted placement